Bolt Biotherapeutics, Inc.
Sheila Gujrathi (Chief Strategy Officer) reports BOLT insider transactions
About this filing
Bolt Biotherapeutics, Inc. (BOLT) filed Form 3 (initial insider holdings) with the SEC on Oct 27, 2026.
Key facts
- Insider
- Sheila Gujrathi · Chief Strategy Officer, Director
No transactions reported; holdings only.
More BOLT filings
- 4
Filed Nov 10, 2026
- 3
Filed Nov 6, 2026
- SC 13G
Filed Nov 6, 2026
- 4
Filed Oct 27, 2026
- 8-K
Filed Oct 23, 2026
- 8-K
Filed Oct 6, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.